𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevalence of mutations related to HIV-1 antiretroviral resistance in Brazilian patients failing HAART

✍ Scribed by Amilcar Tanuri; Elena Caridea; Maria C. Dantas; Marisa G. Morgado; Daise L.C. Mello; Sandra Borges; Marisa Tavares; Selma B. Ferreira; Guilherme Santoro-Lopes; Claudia R.F. Martins; André L.C. Esteves; Ricardo S. Diaz; Sandra M.S. Andreo; Luiz A.P. Ferreira; Rodrigo Rodrigues; Tania Reuter; Ana M.S. Cavalcanti; Suelene M. de Oliveira; Heraclito B. de Barbosa; Paulo R. Teixeira; Pedro N. Chequer


Book ID
117769513
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
121 KB
Volume
25
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Antiretroviral genotypic resistance in p
✍ Annalisa Saracino; Nicola Gianotti; Marianna Marangi; Donatella C. Cibelli; Andr 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

## Abstract The extent to which HIV‐1 proviral DNA mutations cause clinically relevant antiretroviral resistance is still controversial. Paired plasma HIV‐1 RNA and whole blood DNA were compared in patients failing HAART to investigate if the additional knowledge of archived mutations could improve

Analysis of HIV-1 mutation patterns in p
✍ Eugenia Quiros-Roldan; Simona Signorini; Francesco Castelli; Carlo Torti; Andrea 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 27 KB 👁 2 views

The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations

Diverse pattern of protease inhibitor re
✍ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. Sönnerborg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIV‐1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)‐containing therapy. Earlier PI‐naïve patients (n = 172) with NFV‐contain